Analyst Reco. AnGes, Inc.

Equities

Delayed Japan Exchange Other stock markets 04:55:42 13/05/2024 BST			5-day change	1st Jan Change
46 ^JPY	-6.12%		-6.12%	-36.11%

01-19	Eiger BioPharmaceuticals Gets Marketing Approval for Treatment of Ultra-Rare Genetic Disease	MT
01-18	Eiger BioPharmaceuticals, Inc. and Partner, AnGes, Inc. Receive Approval for Zokinvy for Hutchinson- Gilford Progeria Syndrome and Processing-Deficient Progeroid Laminopathies in Japan	CI